SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 📊Experiments 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Index: Therapy Ideas

index 1,198 words 2026-03-30

kind:index section:ideas

Contents

Therapy Ideas

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.66

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 PARP1 Inhibition Therapy
Score: 0.58 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Circadian Clock-Autophagy Synchronization
Score: 0.55 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Temporal Decoupling via Circadian Clock Reset
Score: 0.52 Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 APOE-TREM2 Interaction Modulation
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Magnetosonic-Triggered Transferrin Receptor Clustering
Score: 0.47 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 Pericyte Contractility Reset via Selective PDGFR-β Agonism
Score: 0.44 APOE Isoform Conversion Therapy
Score: 0.44 LRP1-Dependent Tau Uptake Disruption
Score: 0.44 TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43 VCP-Mediated Autophagy Enhancement
Score: 0.41 The Mitochondrial-Lysosomal Metabolic Coupling Dysfunction
Score: 0.40 TFEB-PGC1α Mitochondrial-Lysosomal Decoupling
Score: 0.40 Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.38 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.70 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64

Related Analyses (7)

Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (30)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40

Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 Longitudinal TLR2 reporter gene study in α-synuclein mice
validation · proposed · Score: 0.90 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90 Gandouling protection against brain injury in Wilson's disea
validation · proposed · Score: 0.90 Trehalose-induced lysosomal changes and TFEB activation
exploratory · proposed · Score: 0.90 Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90 Trehalose-induced lysosomal membrane permeabilization and TF
exploratory · proposed · Score: 0.90 Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88 Functional validation of trehalose effects on misfolded prot
exploratory · proposed · Score: 0.85 Dexamethasone treatment study in α-synuclein mice
validation · proposed · Score: 0.85 TLR expression in α-synuclein overexpressing mice
validation · proposed · Score: 0.80 s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40 Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40

Knowledge Graph (8 edges)

OCLN associated_with IMMUNOTHERAPY

C1Q activates CHEMOTHERAPY_RESISTANCE

SLC7A11 associated_with CHEMORADIOTHERAPY

external beam radiotherapy contributes_to second cancer

p53 mutants causes therapy resistance

anti-Aβ immunotherapy activates cerebral amyloid angiopathy

amyloid immunotherapy activates microhemorrhages

SDC1 regulates radiotherapy

SciDEX — scidex.ai — Dashboard | Atlas